Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas

Annals of Diagnostic Pathology

Volumn 15, Issue 6, 2011, Pages 394-401

  Abdou, Asmaa Gaber ^a   Maraee, Alaa Hassan ^a   El Sayed, Eman Mostafa Mohamed ^a   Elnaidany, Nada Farag ^b  

^a MENOUFIA UNIVERSITY   (Egypt)

^b October University for Modern Sciences and Arts   (Egypt)

Author keywords

Epithelial skin tumors; ERM; Ezrin; Immunohistochemistry

Indexed keywords

EZRIN;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; EPIDERMIS CELL; EPITHELIUM TUMOR; FEMALE; HEAD; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NECK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKIN BIOPSY; SKIN CARCINOGENESIS; SKIN CARCINOMA; SKIN EPITHELIUM; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYTOSKELETAL PROTEINS; EPIDERMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 81155131003     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2011.05.005     Document Type: Article

References (37)

1. T.L. Diepgen, and V. Mahler The epidemiology of skin cancer Br J Dermatol 146 61 2002 1 6
2. M.R. Karagas, E.R. Greenberg, and S.K. Spencer Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA Int J Cancer 81 1999 555 559 (Pubitemid 29203052)
3. N. Mokhtar, I. Gouda, and I. Adel Cancer Pathology Regestry (2003-2004): and time trend analysis N. Mokhtar, I. Gouda, I. Adel, Malignant skin tumors 2007 Elsheraa press Cairo 83 86
4. L.J. Christenson, T.A. Borrowman, and C.M. Vachon Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years JAMA 294 2005 681 690 (Pubitemid 41159287)
5. A. Bretscher, K. Edwards, and R.G. Fehon ERM proteins and Merlin: integrators at the cell cortex Nat Rev Mol Cell Biol 3 2002 586 599
6. T.A. Martin, G. Harrison, and R.E. Mansel The role of the CD44/ezrin complex in cancer metastasis [J] Crit Rev Oncol Hematol 46 2003 165 186 (Pubitemid 36452345)
7. P. Pujuguet, L. Del Maestro, and A. Gautreau Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation Mol Biol Cell 14 2003 2181 2191 (Pubitemid 36583562)
8. A. Santos G arc, M.M. Abad Hernandez, and E. Fonseca Snchez Ecadherin, laminin and collagen IV expression in the evolution fromdysplasia to oral squamous cell carcinoma [J] Med Oral Patol Oral Cir Bucal 11 2006 100 105
9. A.C. Broder Practical points on the microscopic grading of carcinoma N Y State J Med 32 1932 667 671
10. L.H. Sobin, and C. Wittekind TNM classification of malignant tumor. International union against cancer (UICC) 6th ed. 2002 Wiley-Liss New York 52 56
11. N. Bilalovic, B. Sandstad, and R. Golouh CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression Mod Pathol 17 2004 1251 1258 (Pubitemid 39312951)
12. H.R. Park, S.K. Min, and K. Min Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma Int J Dermatol 49 2010 48 52
13. H. Zeng, L. Xu, and D. Xiao Altered expression of ezrin in esophageal squamous cell carcinoma J Histochem Cytochem 54 2006 889 896 (Pubitemid 44106866)
14. R. Madan, M. Brandwein-Gensler, and N.F. Schlecht Differential tissue and subcellular expression of ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma Head Neck 28 2006 1018 1027 (Pubitemid 44630942)
15. T. Ichikawa, J. Masumoto, and M. Kaneko Expression of moesin and its associated molecule CD44 in epithelial skin tumors J Cutan Pathol 25 1998 237 243 (Pubitemid 28306512)
16. H. Kobayashi, J. Sagara, and H. Kurita Clinical significance of cellular distribution of moesin in patients with oral squamous cell carcinoma Clin Cancer Res 10 2004 572 580 (Pubitemid 38173996)
17. S.C. Kaul, Y. Mitsui, and Y. Komatsu A highly expressed 81KDa protein in immortalized fibroblast: its proliferative function and identity with ezrin Oncogene 13 1996 1231 1237 (Pubitemid 26343576)
18. J.W. Zhai, X.G. Yang, and F.S. Yang Expression and clinical significance of ezrin and E-cadherin in esophageal squamous cell carcinoma Chinese J Cancer 29 2010 317 320
19. G. Wang, J.S. Zhu, and Q. Zhang High level of ezrin expression in colorectal cancer tissues World J Gastroenterol 15 2009 2016 2019
20. B.E. Elliott, J.A. Meens, and S.K. Sen Gupta The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells Breast Cancer Res 7 2005 R365 R373
21. S.T. Pang, X. Fang, and A. Valdman Expression of ezrin in prostatic intraepithelial neoplasia Urology 63 2004 609 912
22. T.S. Yeh, J.H. Tseng, and N.J. Liu Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma Arch Surg 140 2005 1184 1190
23. M. Tokunou, T. Niki, and Y. Saitoh Altered expression of the ERM proteins in lung adenocarcinoma Lab Invest 80 2000 1643 1650
24. A. Elzagheid, E. Korkeila, and R. Bendardaf Intense Cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer Hum Pathol 39 2008 1737 1743
25. K. Ohtani, H. Sakamoto, and T. Rutherford Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma Cancer Lett 179 2002 79 86 (Pubitemid 34195656)
26. S.A. Tsukita, S. Yonemura, and Tsukita ERM (ezrin/radixin/moesin) family from cytoskeleton to signal transduction Curr Opin Cell Biol 9 1997 70 75 (Pubitemid 27065111)
27. A.N. Crowson Basal cell carcinoma: biology, morphology and clinical implications Mod Pathol 2 2006 S127 S147
28. C. Gupta, D. Sheth, and D.P. Snower Primary basal cell carcinoma of the nipple Arch Pathol Lab Med 128 2004 792 793 (Pubitemid 38856892)
29. R. Betti, C. Crosti, L. Moneghini, E. Crespi, and S. Menni Axillary basal cell carcinoma: additional 25 patients and considerations J Eur Acad Dermatol Venereol 25 2011 858 860
30. N.H. Cox Basal cell carcinoma in young adults Br J Dermato 127 1992 26 29
31. C.J. Milroy, N. Horlock, and G.D. Wilson Aggressive basal cell carcinoma in young patients: fact or fiction? Br J Plast Surg 53 2000 393 396 (Pubitemid 30479642)
32. P. Mhawech-Fauceglia, P. Dulguerov, and A. Beck Value of ezrin, maspin and nm23-H1 protein expression in predicting outcome of patients with head and neck squamous cell carcinoma treated with radical radiotherapy J Clin Pathol 60 2007 185 189
33. S. Ilmonen, A. Vaheri, and S. Asko-Seljavaara Ezrin in primary cutaneous melanoma Mod Pathol 18 2005 503 510 (Pubitemid 40478113)
34. M. Curto, and A.I. McClatchey Ezrin. A metastatic determinant? Cancer Cell 5 2004 113 114
35. K.W. Hunter Ezrin, a key component in tumor metastasis Trends Mol Med 10 2004 201 204 (Pubitemid 38581790)
36. C. Khanna, X. Wan, and S. Bose The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis Nat Med 10 2004 182 186 (Pubitemid 38524889)
37. J. Moilanen, H. Lassus, and A. Leminen Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients Gynecol Oncol 90 2003 273 281 (Pubitemid 36952014)